ArticleFrontiers in microbiology2025
Magnolia essential oil: a preliminary exploration of chemical composition and its antimicrobial and antioxidant potential.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and Characterization ofPharmaceutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the chemical composition of Magnolia essential oil (MEO) was analyzed using gas chromatography-mass spectrometry (GC-MS). The results indicated that terpenoids were the primary constituents, with the main components being 1,8-cineole (44.87%), (+)-citronellal (6.93%), and linalool (29.1%). The antibacterial activity of MEO against four target bacteria was confirmed through inhibition zone assays, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) tests. The bacterial growth curve demonstrated that MEO significantly inhibited bacterial growth and effectively delayed the logarithmic growth phase. Mechanistic studies suggested that MEO primarily acts in the initial stages of bacterial growth by disrupting the bacterial cell membrane, leading to substantial leakage of intracellular materials, impairing metabolic activities, inducing lipid peroxidation, and enhancing oxidative stress, thereby inhibiting normal bacterial proliferation. Furthermore, MEO's antioxidant properties were evaluated through its scavenging effects on DPPH and hydroxyl radicals, as well as its ferric reducing antioxidant power (FRAP). The findings revealed that MEO exhibited the strongest scavenging activity against DPPH radicals, followed by hydroxyl radical scavenging, with the FRAP results being comparatively weaker. These results suggest that MEO not only possesses potent antibacterial effects but also exhibits notable antioxidant activity, indicating potential for broader applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.